Submitted by web@researchtop... on Mon, 06/03/2013 - 12:01
Submitted by web@researchtop... on Mon, 06/03/2013 - 11:50
TARGET AUDIENCE
This activity is intended for medical oncologists, hematologist-oncologists, hematology-oncology fellows, oncology nurses and other practitioners involved in the management of myelofibrosis.
Submitted by web@researchtop... on Tue, 05/28/2013 - 13:43
Patterns of Care Data Regarding Ruxolitinib Use in Patients without JAK2 Mutations
Submitted by web@researchtop... on Mon, 05/27/2013 - 09:35
Allotransplant in patients with MF?
In what situations, if any, do you recommend allotransplant to patients with MF?
Submitted by web@researchtop... on Mon, 05/27/2013 - 09:33
Splenectomy in patients with MF?
Presently, how often do you recommend splenectomy to patients with MF?
Submitted by web@researchtop... on Fri, 05/24/2013 - 15:24
Other diseases most commonly confused with MF?
Based on your clinical experience, which of the following disease states is most often confused with a diagnosis of myelofibrosis (MF)?
Submitted by web@researchtop... on Fri, 05/24/2013 - 12:50
Submitted by web@researchtop... on Fri, 05/24/2013 - 10:00
TARGET AUDIENCE
This activity is intended for medical oncologists, hematologist-oncologists, hematology-oncology fellows, oncology nurses and other practitioners involved in the management of myelofibrosis.
Submitted by web@researchtop... on Tue, 05/21/2013 - 14:40
Submitted by web@researchtop... on Tue, 05/21/2013 - 13:09
Submitted by web@researchtop... on Tue, 05/21/2013 - 13:08
Submitted by web@researchtop... on Tue, 05/21/2013 - 13:08
Submitted by web@researchtop... on Tue, 05/21/2013 - 13:08
Submitted by web@researchtop... on Tue, 05/21/2013 - 13:07
Submitted by web@researchtop... on Tue, 05/21/2013 - 13:07